Ikarian Capital, LLC Nuvation Bio Inc. Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 83,407 shares of NUVB stock, worth $168,482. This represents 0.04% of its overall portfolio holdings.
Number of Shares
83,407
Previous 83,282
0.15%
Holding current value
$168,482
Previous $191,000
15.71%
% of portfolio
0.04%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
151MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$52.4 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$32.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$31.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$26.4 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$18.6 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $439M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...